Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis

NCT07718529 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis in Remission

Interventions

DRUG: treatment withdrawal

Sponsor

Assistance Publique Hopitaux De Marseille